An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors
- PMID: 22476439
- DOI: 10.1007/s00520-012-1445-4
An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors
Abstract
Objectives: The choice of appropriate neuropsychological tests is important in evaluating the onset, severity, duration, and site of cognitive changes in postchemotherapy breast cancer survivors. This literature review is designed to evaluate and provide a summary of suitable neuropsychological tests to determine cognitive changes in breast cancer survivors.
Method: A literature search restricted to publications in English before June 2011 was performed using the following combination of keywords: "neuropsychological assessments," "breast cancer," "chemotherapy," and "cognitive impairment." Only observational studies that performed cognitive assessments on breast cancer survivors were included. The neuropsychological assessments were grouped as "objective" (traditional batteries and screening tests), "subjective," or "computerized."
Results: Of the 43 studies extracted, memory (88 %) and attention/concentration (88 %) are the two most commonly assessed domains. A majority (63 %) employed the use of Wechsler Adult Intelligent Scale (an objective test), while only 49 % incorporated subjective assessments to assess perceived cognitive impairment. Computerized tests received low popularity (28 %) despite their numerous advantages, which include overcoming the language- and cultural-dependent limitations of traditional objective tests.
Conclusions: In the selection of a suitable neuropsychological tool to determine the onset, severity, site, and duration of cognitive changes in breast cancer survivors, incorporation of both subjective and objective tests is essential to facilitate a comprehensive assessment. With more validation work performed in future studies, it may be feasible to employ computerized neuropsychological assessments in both clinical and research settings.
Similar articles
-
The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.Patient Educ Couns. 2007 Apr;66(1):108-18. doi: 10.1016/j.pec.2006.11.005. Epub 2007 Feb 21. Patient Educ Couns. 2007. PMID: 17320337
-
A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.Oncol Nurs Forum. 2007 Sep;34(5):997-1005. doi: 10.1188/07.ONF.997-1005. Oncol Nurs Forum. 2007. PMID: 17878128 Review.
-
Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.J Clin Oncol. 2017 Feb 10;35(5):506-514. doi: 10.1200/JCO.2016.68.5826. Epub 2016 Dec 28. J Clin Oncol. 2017. PMID: 28029304 Free PMC article.
-
Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.J Clin Oncol. 2012 Oct 10;30(29):3578-87. doi: 10.1200/JCO.2011.39.5640. Epub 2012 Aug 27. J Clin Oncol. 2012. PMID: 22927526 Free PMC article. Review.
-
Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors.J Psychosoc Oncol. 2009;27(4):415-34. doi: 10.1080/07347330903183117. J Psychosoc Oncol. 2009. PMID: 19813133 Free PMC article.
Cited by
-
Postoperative serum CHI3L1 level is associated with postoperative cognitive dysfunction in elderly patients after hip fracture surgery: A prospective observational study.Heliyon. 2023 Jul 29;9(8):e18796. doi: 10.1016/j.heliyon.2023.e18796. eCollection 2023 Aug. Heliyon. 2023. PMID: 37609401 Free PMC article.
-
Associations Between Physical Fitness Indices and Working Memory in Breast Cancer Survivors and Age-Matched Controls.J Womens Health (Larchmt). 2016 Jan;25(1):99-108. doi: 10.1089/jwh.2015.5246. Epub 2015 Sep 29. J Womens Health (Larchmt). 2016. PMID: 26418463 Free PMC article.
-
Linguistic validation of Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog): methodological concerns.Support Care Cancer. 2013 Mar;21(3):655-6. doi: 10.1007/s00520-012-1631-4. Epub 2012 Oct 23. Support Care Cancer. 2013. PMID: 23089944 No abstract available.
-
Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.Pharmacotherapy. 2019 May;39(5):553-563. doi: 10.1002/phar.2259. Epub 2019 Apr 4. Pharmacotherapy. 2019. PMID: 30892712 Free PMC article.
-
Effectiveness of a mobile-based return to work program for decent return to work, fatigue, stress, and quality of working life among cancer survivors.J Cancer Surviv. 2025 Apr;19(2):713-727. doi: 10.1007/s11764-024-01570-x. Epub 2024 May 21. J Cancer Surviv. 2025. PMID: 38769245
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical